Alembic Pharmaceuticals has secured tentative approval from the USFDA for its generic version of Darolutamide tablets, targeting prostate c...

Roche Pharma has introduced Tecentriq, India's first under-the-skin immunotherapy for lung cancer. This new injection takes about seven min...

Twelve Indian companies announced over USD 1.1 billion in US investments across aerospace, defense, energy, and AI sectors at the SelectUSA...

Aurobindo Pharma announced a significant development today. Its subsidiary, CuraTeQ Biologics, has received a compliance notice from Health...

The Delhi High Court has permitted Natco Pharma to launch its affordable generic version of risdiplam, a crucial drug for spinal muscular a...

Swiss healthcare major Roche Pharma is committing 1.5 billion Swiss Francs to India over the next five years, focusing on core businesses a...

Roche Pharma collaborates with ten government hospitals. The goal is to improve clinical trial capabilities across India. Nearly 400 profes...

Roche Pharma India has announced that Rajwinder Mehdwan will take over as the country general manager from April 1, 2025, replacing V Simps...

Roche Pharma India launches Vabysmo, a medication for neovascular age-related macular degeneration and diabetic macular edema in India. The...

The company has introduced Ocrevus (Ocrelizumab) which is the first and only approved disease modifying therapy for both Relapsing Remittin...

PHESGO was first approved by the US FDA in June 2020 during the peak of the Covid pandemic, by the European Medicines Agency (EMA) in Decem...

Since its launch, over 4,000 SMA patients across over 50 countries have benefitted from the drug, Roche said in a statement.

Roche said that the production process for this drug is “very complex” and the company will do everything to ensure an equitable distributi...

Roche Pharma India has signed a "distribution agreement with Cipla to expand the scope of the partnership to include, marketing and distrib...

Roche said this partnership will also enable it to focus on bringing new, transformative medicines to patients in India.

The pharma major will distribute Tocilizumab and Syndyma -- the second brand of Roche's cancer therapy bevacizumab -- in India.

Roche announced on Thursday that it had signed a marketing agreement with domestic company Elder Pharma for its osteoporosis drug, Bonviva.